Immunotherapy for allergy treatment must be taken for several years. In this video, HealthMaker Alkis Togias, MD, Asthma and Inflammation Section Chief at the NIAID, explains what scientists know about the long-term benefits of this treatment.
Alkis Togias, MD is the Chief of the Asthma and Inflammation Section, Division of Allergy, Immunology, and Transplantation at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. He has worked in this field for more than a quarter of a century. As branch chief, he plays a leading role on the present and future of medical research in asthma.
View Profile